<?xml version="1.0" encoding="UTF-8"?>
<p>The principle of gout management is based on reducing and maintaining the serum urate at the normal value (&lt;6.0â€‰mg/d) [
 <xref rid="B9" ref-type="bibr">9</xref>]. Generally, there are three methods employed to reach this objective. The first one allows inhibiting the xanthine oxidase enzyme (allopurinol and febuxostat) and then blocking the production of uric acid and their precursor. The second one is intended to enhance uric acid excretion. The third strategy is based on the administration of recombinant uricases to convert uric acid to allantoin (
 <xref rid="tab1" ref-type="table">Table 1</xref>) [
 <xref rid="B9" ref-type="bibr">9</xref>, 
 <xref rid="B20" ref-type="bibr">20</xref>].
</p>
